Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease

Cannabinoids and Parkinsons Disease

(2012) Moises Garcia-Arencibia et al.   CNS & Neurological Disorders-Drug Targets

The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice

(2010) Daniele Bolognini et al.   BRITISH JOURNAL OF PHARMACOLOGY

Levodopa in Parkinson's disease: from the past to the future

(2010) Gianni Pezzoli et al.   EXPERT OPINION ON PHARMACOTHERAPY

The CB1 antagonist rimonabant is adjunctively therapeutic as well as monotherapeutic in an animal model of Parkinson's disease

(2009) J.E. Kelsey et al.   BEHAVIOURAL BRAIN RESEARCH

WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease

(2009) David A. Price et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Intrastriatal lipopolysaccharide injection induces parkinsonism in C57/B6 mice

(2009) Randy L. Hunter et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors

(2009) Sandra Pérez-Rial et al.   NEUROBIOLOGY OF AGING

Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity

(2008) Louise Adermark et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats

(2008) Moisés García-Arencibia et al.   NEUROSCIENCE LETTERS

The cannabinoid CP55,940 prolongs survival and improves locomotor activity in Drosophila melanogaster against paraquat: Implications in Parkinson's disease

(2008) M. Jimenez-Del-Rio et al.   NEUROSCIENCE RESEARCH

The peripheral cannabinoid receptor knockout mice: an update

(2007) N E Buckley   BRITISH JOURNAL OF PHARMACOLOGY

The psychoactive plant cannabinoid, Δ9-tetrahydrocannabinol, is antagonized by Δ8- and Δ9-tetrahydrocannabivarin in mice in vivo

(2007) R G Pertwee et al.   BRITISH JOURNAL OF PHARMACOLOGY

Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and α-synuclein-deleted mice

(2007) Daniel Alvarez-Fischer et al.   EXPERIMENTAL NEUROLOGY